DECIPHERA PHARMACEUTICALS IN's ticker is and the CUSIP is 24344T951. A total of 3 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14 | -41.7% | 1,000 | -37.5% | 0.00% | – |
| Q1 2023 | $24 | +33.3% | 1,600 | +45.5% | 0.00% | – |
| Q4 2022 | $18 | -99.8% | 1,100 | -8.3% | 0.00% | – |
| Q1 2022 | $11,000 | -88.9% | 1,200 | -88.2% | 0.00% | – |
| Q4 2021 | $99,000 | +26.9% | 10,200 | +385.7% | 0.00% | – |
| Q3 2021 | $78,000 | +2.6% | 2,100 | 0.0% | 0.00% | – |
| Q2 2021 | $76,000 | -5.0% | 2,100 | +11566.7% | 0.00% | – |
| Q1 2021 | $80,000 | -48.1% | 18 | -33.3% | 0.00% | – |
| Q4 2020 | $154,000 | +15.8% | 27 | +3.8% | 0.00% | – |
| Q3 2020 | $133,000 | -67.2% | 26 | -61.8% | 0.00% | -100.0% |
| Q2 2020 | $406,000 | +192.1% | 68 | +100.0% | 0.00% | – |
| Q1 2020 | $139,000 | -6.7% | 34 | +41.7% | 0.00% | – |
| Q4 2019 | $149,000 | +547.8% | 24 | +242.9% | 0.00% | – |
| Q3 2019 | $23,000 | +1050.0% | 7 | +600.0% | 0.00% | – |
| Q2 2019 | $2,000 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 1,200 | $11,000 | 0.00% |